Author Correction: Parathyroid hormone receptor agonists in the management of osteoporosis.

IF 32.7 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2025-09-30 DOI:10.1038/s41584-025-01314-w

Nicholas Fuggle,René Rizzoli,Charlotte Beaudart,Bernard Cortet,Elizabeth M Curtis,Mickaël Hiligsmann,Jean-Marc Kaufman,Nicola Veronese,Ben Hur Albergaria,Nasser Al-Daghri,Majed Alokail,Maria Luisa Brandi,Olivier Bruyère,Nansa Burlet,Claudia Campusano,Enrique Casado,Etienne Cavalier,Manju Chandran,Cyrus Cooper,Patrizia D'Amelio,Bess Dawson-Hughes,Peter R Ebeling,John A Kanis,Andreas Kurth,Radmila Matijevic,Eugene McCloskey,Michael McClung,Ouafa Mkinsi,Ngozi Njeze,Régis P Radermecker,François Rannou,Stuart Silverman,Şansın Tüzün,Leith Zakraoui,Jean-Yves Reginster,Nicholas C Harvey

引用次数: 0

查看原文本刊更多论文

作者更正：甲状旁腺激素受体激动剂在骨质疏松症的管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.